We are live on
!
Find out more
ACM
Alethea Capital Management Portfolio holdings
AUM
$195M
1-Year Est. Return
51.17%
This Fund
S&P 500
This Quarter
Est. Return
-8.3%
1 Year Est. Return
+51.17%
3 Year Est. Return
+200.24%
5 Year Est. Return
+277.75%
10 Year Est. Return
+2,049.08%
AUM
$79.9M
AUM Growth
-$30.7M
(-28%)
Cap. Flow
-$18.9M
Cap. Flow
% of AUM
-23.6%
Top 10 Holdings %
Top 10 Hldgs %
76.99%
Holding
80
New
15
Increased
5
Reduced
30
Closed
16
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$548K |
| 2 |
WBA
Walgreens Boots Alliance
WBA
|
+$528K |
| 3 |
Philip Morris
PM
|
+$513K |
| 4 |
Corning
GLW
|
+$510K |
| 5 |
Hasbro
HAS
|
+$500K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Axsome Therapeutics
AXSM
|
+$8.01M |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.41M |
| 3 |
CTRA
Coterra Energy
CTRA
|
+$1.02M |
| 4 |
RTX Corp
RTX
|
+$934K |
| 5 |
Williams Companies
WMB
|
+$925K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 66.61% |
| 2 | Financials | 4.31% |
| 3 | Consumer Staples | 4.09% |
| 4 | Technology | 3.61% |
| 5 | Industrials | 3.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Axsome Therapeutics
AXSM
$12.4B
| $30.3M | 37.87% |
789,813
-253,346
| -24% | -$8.01M |
|
|
RNAM
2
DELISTED
Avidity Biosciences
RNAM
| $12.1M | 15.2% |
835,473
-54,484
| -6% | -$811K |
|
3
Kura Oncology
KURA
$922M
| $6.72M | 8.41% |
366,569
+8,949
| +3% | +$129K |
|
4
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
$46.8B
| $5.78M | 7.23% |
63,166
| – | – |
|
|
5
iShares 20+ Year Treasury Bond ETF
TLT
$42.1B
| $2.78M | 3.48% |
24,200
-11,972
| -33% | -$1.41M |
|
6
Kimberly-Clark
KMB
$36.4B
| $884K | 1.11% |
6,538
+3,338
| +104% | +$440K |
|
|
CDTX
7
DELISTED
Cidara Therapeutics
CDTX
| $819K | 1.03% |
83,860
-13,103
| -14% | -$162K |
|
8
Home Depot
HD
$332B
| $748K | 0.94% |
2,729
+1,429
| +110% | +$422K |
|
9
Illinois Tool Works
ITW
$81.4B
| $730K | 0.91% |
4,004
+2,004
| +100% | +$401K |
|
10
Verizon
VZ
$194B
| $653K | 0.82% |
12,876
-4,653
| -27% | -$235K |
|
|
SPPI
11
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $615K | 0.77% |
787,973
-389,142
| -33% | -$343K |
|
|
12
Gilead Sciences
GILD
$161B
| $547K | 0.68% |
+8,850
| New | +$548K |
|
13
IBM
IBM
$202B
| $513K | 0.64% |
+3,634
| New | +$490K |
|
14
Colgate-Palmolive
CL
$72.6B
| $499K | 0.62% |
+6,232
| New | +$487K |
|
|
15
Philip Morris
PM
$301B
| $497K | 0.62% |
+5,030
| New | +$513K |
|
|
16
Hasbro
HAS
$12.6B
| $472K | 0.59% |
+5,768
| New | +$500K |
|
|
17
Corning
GLW
$126B
| $466K | 0.58% |
+14,804
| New | +$510K |
|
|
WBA
18
DELISTED
Walgreens Boots Alliance
WBA
| $465K | 0.58% |
+12,282
| New | +$528K |
|
19
Alliant Energy
LNT
$19.4B
| $443K | 0.55% |
+7,563
| New | +$457K |
|
20
Alphabet (Google) Class C
GOOG
$3.9T
| $427K | 0.53% |
3,900
-1,200
| -24% | -$142K |
|
21
Whirlpool
WHR
$2.42B
| $424K | 0.53% |
+2,735
| New | +$476K |
|
22
ExxonMobil
XOM
$651B
| $420K | 0.53% |
4,900
-2,100
| -30% | -$189K |
|
23
AT&T
T
$165B
| $419K | 0.52% |
+19,996
| New | +$399K |
|
24
Citigroup
C
$222B
| $407K | 0.51% |
8,848
-3,641
| -29% | -$182K |
|
|
BNY
25
Bank of New York Mellon
BNY
$108B
| $397K | 0.5% |
+9,521
| New | +$424K |
|
Similar funds
WM
LWA
CPI
WAL
NLWP
ICMARC
RAM
MHFA
Alethea Capital Management's Q2 2022 Portfolio in Review
As of Q2 2022, Alethea Capital Management held 80 positions worth $79.9M, down 28% from $111M the previous quarter. Its ten largest holdings account for 77% of the portfolio.
Alethea Capital Management withdrew a net $18.9M in Q2 2022, closing 16 positions and reducing 30 holdings. Its most notable exit was Coterra Energy, an estimated $1.02M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 67% of assets, up from 65% a quarter earlier, followed by Financials and Consumer Staples.
Against the trend, Alethea Capital Management opened a new position in Gilead Sciences worth $547K.
- Alethea Capital Management's largest Q2 2022 buy was Gilead Sciences: 8,850 shares worth $547K.
- Alethea Capital Management added most to Kimberly-Clark in Q2 2022, an estimated $440K increase.
- Alethea Capital Management's biggest Q2 2022 reduction was Axsome Therapeutics, cutting an estimated $8.01M.
- Alethea Capital Management fully exited Coterra Energy in Q2 2022, selling an estimated $1.02M.
- Alethea Capital Management's ten largest holdings make up 77% of its $79.9M portfolio in Q2 2022.
- Alethea Capital Management opened 15 new positions and closed 16 in Q2 2022.
- Alethea Capital Management's portfolio value fell 28% quarter-over-quarter to $79.9M.
Based on Alethea Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.